|
PRKCI expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.524170E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.928100E-02 |
| Normal-vs-Stage2 |
2.159600E-01 |
| Normal-vs-Stage3 |
7.821800E-01 |
| Normal-vs-Stage4 |
4.590000E-01 |
| Stage1-vs-Stage2 |
7.872000E-01 |
| Stage1-vs-Stage3 |
3.757600E-01 |
| Stage1-vs-Stage4 |
7.328800E-01 |
| Stage2-vs-Stage3 |
3.708200E-01 |
| Stage2-vs-Stage4 |
8.263800E-01 |
| Stage3-vs-Stage4 |
5.278600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.858100E-02 |
| Normal-vs-AfricanAmerican |
1.625610E-01 |
| Normal-vs-Asian |
8.756400E-01 |
| Caucasian-vs-AfricanAmerican |
5.510200E-01 |
| Caucasian-vs-Asian |
6.406200E-01 |
| AfricanAmerican-vs-Asian |
7.228800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.637600E-02 |
| Normal-vs-Female |
1.362340E-02 |
| Male-vs-Female |
2.025000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.727400E-01 |
| Normal-vs-Extreme_Weight |
3.166400E-01 |
| Normal-vs-Obese |
2.897900E-02 |
| Normal-vs-Extreme_Obese |
9.878200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.876200E-01 |
| Normal_Weight-vs-Obese |
2.899800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.750600E-01 |
| Extreme_Weight-vs-Obese |
2.015400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.396400E-01 |
| Obese-vs-Extreme_Obese |
2.653400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.824450E-02 |
| Normal-vs-Age(41-60Yrs) |
3.163000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.270400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.801240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.049800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.682100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.219800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.846100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.422000E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.291500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.620400E-04 |
| Normal-VS-Type2 PRCC |
4.406200E-02 |
| Normal-VS-KIRP CIMP |
1.046110E-02 |
| Normal-VS-Unclassified PRCC |
7.210100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.7094004817485E-10 |
| Type1 PRCC-VS-KIRP CIMP |
4.564200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.492000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.755400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.922350E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.379890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.101600E-01 |
| Normal-vs-N1 |
2.422400E-02 |
| Normal-vs-N2 |
6.513200E-01 |
| N0-vs-N1 |
2.075500E-02 |
| N0-vs-N2 |
6.171400E-01 |
| N1-vs-N2 |
8.436200E-01 |
|
|
